Brain-computer interface technology ushered in new breakthroughs, and future giants compete for new heights

On May 26, Beijing time, Neuralink, a brain-computer interface company owned by Musk, officially announced that its first human clinical trial was approved by the U.S. Food and Drug Administration (FDA). According to Musk, Neuralink is designing a device that converts brain signals into actions. It will first focus on two applications: one is to restore human vision, and the other is to help people who cannot move muscles control devices such as smartphones, and even restore the spinal cord. Systemic functioning of the impaired person.

The Neural Link Twitter account posted: We are pleased to report that we have received approval from the U.S. Food and Drug Administration to initiate our first-in-human clinical study. This is an incredible result achieved by the Neural Chain team in close collaboration with the U.S. Food and Drug Administration, and represents an important first step in how, one day, our technology will help many people. Our clinical trials have not yet started recruiting. We will announce more information about this soon.

Immediately, Musk forwarded this tweet and said: Congratulations, Neural Chain Team!

Within a few minutes, there were tens of thousands of messages, but one message stood out: Congratulations, your neural network is even more than meets the eye. I believe in his concept and what you have done is amazing. Yet I suspect Musk is using neurotechnology to pursue immortality. This way he can see his ultimate goal of colonizing Mars.

A message was received saying: "I want to be one of the first to get it. I understand all the risks and will sign the necessary agreements.". In 1999, a dreamer said that he used neural chains in my dreams, and he also told me about the starship that he had spent 24 years waiting for this and that they were connected.

Elon Musk may be the greatest entrepreneur in history, attracting the best minds from multiple industries to develop breakthrough technologies that drive human progress.

Congratulations to the Neural Link team, your team’s hard work and dedication on this critical achievement brings us one step closer to unlocking unprecedented opportunities for human health and cognitive abilities.

This is a landmark achievement. The Neural Link team’s groundbreaking work has been approved by the U.S. Food and Drug Administration, demonstrating the potential impact your technology can have on improving lives. We look forward to further updates on clinical trial recruitment, as well as to seeing the positive results of this innovative effort and continuing the great work.

marvelous! Every day, Elon Musk and his team lead us towards a more advanced society and a new era! . Because I am very interested in the research results of the Neural Link team, I can’t wait to see the results of their first human experiments.

Warm congratulations to the entire NeuralLink team, this is a major advance in the field of neurotechnology and your pioneering work has the potential to revolutionize the treatment of many neurological diseases. Eagerly awaiting updates on upcoming clinical trials, keep up the amazing work.

The U.S. Food and Drug Administration has approved the first human clinical study of brain-computer interface, which is of great significance to the development and application of brain-computer interface technology.

First of all, this approval marks that brain-computer interface technology has moved from the laboratory to human clinical application, which will promote the maturity and development of brain-computer interface technology.

Secondly, this approval also brings hope to patients with severe physical disabilities such as spinal cord injury, paralysis, and blindness. Implanted brain-computer interface devices can allow them to restore some or all of their body functions, thereby improving their quality of life.

In addition, the clinical application of brain-computer interface technology will also bring more opportunities and challenges to mankind, such as the development and application of human-computer interaction, artificial intelligence, cognitive science and other fields.

In short, the U.S. Food and Drug Administration’s approval of brain-computer interface to launch the first human clinical study is an important milestone, which will promote the development and application of brain-computer interface technology and bring more opportunities and challenges to mankind.

The above is the detailed content of Brain-computer interface technology ushered in new breakthroughs, and future giants compete for new heights. For more information, please follow other related articles on the PHP Chinese website!